Validation of the 4-item PRECISE-DAPT score : A SWEDEHEART study
(2021) In Journal of the American Heart Association 10(20).- Abstract
BACKGROUND: The Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score has been shown to predict out-of-hospital major bleeding after myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy (DAPT). However, large validation studies have been scarce and the discriminative ability for patients with a preexisting bleeding risk factor (elderly, underweight, women, anemia, kidney dysfunction, or cancer) in a real-world setting is unknown. METHODS AND RESULTS: Patients undergoing percutaneous coronary intervention for myocardial infarction between 2008 and 2017 were included from the SWEDEHEART (Swedish Web System for... (More)
BACKGROUND: The Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score has been shown to predict out-of-hospital major bleeding after myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy (DAPT). However, large validation studies have been scarce and the discriminative ability for patients with a preexisting bleeding risk factor (elderly, underweight, women, anemia, kidney dysfunction, or cancer) in a real-world setting is unknown. METHODS AND RESULTS: Patients undergoing percutaneous coronary intervention for myocardial infarction between 2008 and 2017 were included from the SWEDEHEART (Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) registry (n=66 295). The predictive value of the PRECISE-DAPT score for rehospitalization with major bleeding during dual antiplatelet therapy was evaluated using receiver operating char-acteristic analyses. A high PRECISE-DAPT score (≥25; n=13 894) was associated with increased risk of major bleeding (3.9% versus 1.8%; hazard ratio [HR], 2.2; 95% CI, 2.0– 2.5; P<0.001) compared with a non-high score (<25; n=52 401). The score demonstrated a c-statistic of 0.64 (95% CI, 0.63– 0.66). The discriminative ability of the score to further stratify bleeding risk in patients with preexisting bleeding risk factors was poor, especially in patients who are elderly (c-statistic=0.57; 95% CI, 0.55– 0.60) or underweight (c-statistic=0.56; 95% CI, 0.51– 0.61), for whom a non-high PRECISE-DAPT score was associated with similar bleeding risk as a high PRECISE-DAPT score in the general myocardial infarction population. CONCLUSIONS: In this nationwide population-based study, the PRECISE-DAPT score performed moderately in the general my-ocardial infarction population and poorly in patients with preexisting bleeding risk factors, where its usefulness seems limited.
(Less)
- author
- Wester, Axel LU ; Mohammad, Moman A. LU ; Olivecrona, Göran LU ; Holmqvist, Jasminka ; Yndigegn, Troels LU and Koul, Sasha LU
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Bleeding, Dual antiplatelet therapy, Myocardial infarction, PRECISE-DAPT, SWEDEHEART
- in
- Journal of the American Heart Association
- volume
- 10
- issue
- 20
- article number
- e020974
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:85119303722
- pmid:34612051
- ISSN
- 2047-9980
- DOI
- 10.1161/JAHA.121.020974
- language
- English
- LU publication?
- yes
- id
- 0531e923-8d0f-4e80-ad85-12a16f2cbbf5
- date added to LUP
- 2021-12-03 13:26:59
- date last changed
- 2024-09-23 08:03:45
@article{0531e923-8d0f-4e80-ad85-12a16f2cbbf5, abstract = {{<p>BACKGROUND: The Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score has been shown to predict out-of-hospital major bleeding after myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy (DAPT). However, large validation studies have been scarce and the discriminative ability for patients with a preexisting bleeding risk factor (elderly, underweight, women, anemia, kidney dysfunction, or cancer) in a real-world setting is unknown. METHODS AND RESULTS: Patients undergoing percutaneous coronary intervention for myocardial infarction between 2008 and 2017 were included from the SWEDEHEART (Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) registry (n=66 295). The predictive value of the PRECISE-DAPT score for rehospitalization with major bleeding during dual antiplatelet therapy was evaluated using receiver operating char-acteristic analyses. A high PRECISE-DAPT score (≥25; n=13 894) was associated with increased risk of major bleeding (3.9% versus 1.8%; hazard ratio [HR], 2.2; 95% CI, 2.0– 2.5; P<0.001) compared with a non-high score (<25; n=52 401). The score demonstrated a c-statistic of 0.64 (95% CI, 0.63– 0.66). The discriminative ability of the score to further stratify bleeding risk in patients with preexisting bleeding risk factors was poor, especially in patients who are elderly (c-statistic=0.57; 95% CI, 0.55– 0.60) or underweight (c-statistic=0.56; 95% CI, 0.51– 0.61), for whom a non-high PRECISE-DAPT score was associated with similar bleeding risk as a high PRECISE-DAPT score in the general myocardial infarction population. CONCLUSIONS: In this nationwide population-based study, the PRECISE-DAPT score performed moderately in the general my-ocardial infarction population and poorly in patients with preexisting bleeding risk factors, where its usefulness seems limited.</p>}}, author = {{Wester, Axel and Mohammad, Moman A. and Olivecrona, Göran and Holmqvist, Jasminka and Yndigegn, Troels and Koul, Sasha}}, issn = {{2047-9980}}, keywords = {{Bleeding; Dual antiplatelet therapy; Myocardial infarction; PRECISE-DAPT; SWEDEHEART}}, language = {{eng}}, number = {{20}}, publisher = {{Wiley-Blackwell}}, series = {{Journal of the American Heart Association}}, title = {{Validation of the 4-item PRECISE-DAPT score : A SWEDEHEART study}}, url = {{http://dx.doi.org/10.1161/JAHA.121.020974}}, doi = {{10.1161/JAHA.121.020974}}, volume = {{10}}, year = {{2021}}, }